rhBMP-2/CPM

DRUG5 trials

Sponsors

Wyeth is now a wholly owned subsidiary of Pfizer

Conditions

FracturesOsteoarthritisRadius Fractures

Phase 1

Study Evaluating rhBMP-2/CPM in Closed Distal Radius Fractures

CompletedNCT00161629

Wyeth is now a wholly owned subsidiary of PfizerRadius Fractures

Start: 2005-09-30End: 2007-01-31Target: 40Updated: 2007-12-05

Study Evaluating rhMBP-2/CPM in Open Wedge Osteotomies

CompletedNCT00243295

Wyeth is now a wholly owned subsidiary of PfizerOsteoarthritis

Start: 2003-11-30End: 2005-03-31Target: 6Updated: 2006-10-06

Phase 2

Feasibility And Safety Study Of rhBMP-2/CPM For Hip Fractures

CompletedNCT00384358

Wyeth is now a wholly owned subsidiary of PfizerFractures

Start: 2006-12-31End: 2010-06-30Updated: 2013-02-28

A Study of rhBMP-2/CPM in Closed Fractures of the Humerus

CompletedNCT00384852

Wyeth is now a wholly owned subsidiary of PfizerFractures

Start: 2007-01-31End: 2010-02-28Updated: 2013-02-28

A Phase 2/3 Multicenter, Controlled Trial Of rhBMP-2/CPM In Tibial Fractures

TerminatedNCT00387686

Wyeth is now a wholly owned subsidiary of PfizerFractures

Start: 2006-11-30End: 2010-03-31Updated: 2013-02-28

Related Papers

Warwick Hip Trauma Study: a randomised clinical trial comparing interventions to improve outcomes in internally fixed intracapsular fractures of the proximal femur. Protocol for the WHiT Study.

2010-08-1711 citations